Sanofi will offer a 30-day supply of any combination, type or quantity of their insulin for $35 to all patients with a valid prescription, regardless of income or insurance status, starting January 1, 2026, according to a recent company news release . This fixed monthly rate will be available through their Insulins Valyou Savings Program, which was originally established for patients without health insurance.

Insulin brands covered include:

Admelog (insulin lispro)

Apidra (insulin glulisine)

Lantus(insulin glargine)

Merilog (insulin aspart-szjj)

Soliqua100/33 (insulin glargine and lixisenatide)

Toujeo (insulin glargine)

"Our announcement builds on an idea first championed by President Trump to lower costs for American patients at the pharmacy counter,” Adam Gluck, head of U.S. co

See Full Page